EP4302832A1 — Palbociclib formulation containing glucono delta lactone
Assigned to Lotus Pharmaceutical Co Ltd · Expires 2024-01-10 · 2y expired
What this patent protects
The present invention relates to a pharmaceutical solid composition, containing palbociclib or a pharmaceutically acceptable salt thereof; gluconic acid and/or derivative thereof; and optionally one or more further water-soluble acids. The composition shows improved dissolu…
USPTO Abstract
The present invention relates to a pharmaceutical solid composition, containing palbociclib or a pharmaceutically acceptable salt thereof; gluconic acid and/or derivative thereof; and optionally one or more further water-soluble acids. The composition shows improved dissolution properties, compared to prior art compositions.
Drugs covered by this patent
- Palbociclib (palbociclib) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.